Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CD44 | P16070 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21175202 | 0.97 | ALDH1A1 (0.45) | ALDH1A1TSHRPDE10ACASP1CYP3A4 | |
| SCHEMBL15573628 | 0.86 | ALDH1A1 (0.41) | ALDH1A1TSHRPDE10ACASP1CYP3A4 | |
| SCHEMBL524410 | 0.83 | GAA (0.40) | ALDH1A1TSHRCYP3A4TDP1MAPK1 | |
| SCHEMBL38651837 | 0.82 | GAA (0.46) | ALDH1A1TSHRPDE10ACASP1CYP3A4 | |
| SCHEMBL22644377 | 0.82 | CYP3A4 (0.48) | ALDH1A1TSHRPDE10ACASP1CYP3A4 | |
| SCHEMBL13928793 | 0.82 | ALDH1A1 (0.38) | ALDH1A1TSHRPDE10ACASP1 | |
| Hydrochloric Acid SCHEMBL524876 | 0.82 | GAA (0.43) | ALDH1A1TSHRCYP3A4TDP1MAPK1 | |
| SCHEMBL25112322 | 0.78 | NOS3 (0.39) | ALDH1A1TSHRPDE10AMAPTKMT2A | |
| SCHEMBL16236972 | 0.78 | TSHR (0.43) | ALDH1A1TSHRPDE10AMAPK1MAPT | |
| SCHEMBL16236862 | 0.77 | KDM4E (0.40) | ALDH1A1TSHRMAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-07-01 | — | — | US | claimed |
| CN-118388315-A | Method for synthesizing 1, 5-dibromo-2, 4-bis (bromomethyl) -3-fluorobenzene and application thereof | 常州贝迪佳尔生物科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-0488756-B1 | Oxidizable color producing reagent | WAKO PURE CHEM IND LTD (JP) | 1997-02-26 | — | — | EP | claimed |
| CN-122079814-A | Synthesis method of 4-fluoro-3, 5-dimethylbenzene hydrazine hydrochloride | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260103463-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-04-16 | — | — | US | disclosed |
| US-20260055105-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-02-26 | — | — | US | disclosed |
| CN-120757464-A | Preparation method of 4-fluoro-3, 5-dimethylbenzene hydrazine hydrochloride | 内蒙古幸源新材料科技有限公司 | 2025-10-10 | — | — | CN | disclosed |
| US-12410168-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-09 | — | — | US | disclosed |
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2025137307-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20120028923-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | RIGEL PHARMACEUTICALS, INC. | 2012-02-02 | — | — | US | disclosed |
| US-20120028923-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | RIGEL PHARMACEUTICALS, INC. | 2012-02-02 | — | — | US | disclosed |
| WO-2008094592-A1 | HYDROXAMIC ACID DERIVATIVES OF ANILINE USEFUL AS THERAPEUTIC AGENTS FOR TREATING ANTHRAX POISONING | PANTHERA BIOPHARNA, LLC (US) | 2008-08-07 | — | — | WO | disclosed |
| EP-0488756-B1 | Oxidizable color producing reagent | WAKO PURE CHEM IND LTD (JP) | 1997-02-26 | — | — | EP | disclosed |
| US-5279714-A | Reductive fluorination of nitrobenzene | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-01-18 | — | — | US | disclosed |
| US-5238818-A | Derivative of p-fluoroaniline with 4-aminoantipyrine | WAKO PURE CHEMICALS CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0508578-A2 | Preparation of Fluoroanilines by Electrochemical Means | ZENECA LIMITED (GB) | 1992-10-14 | — | — | EP | disclosed |
| EP-0488756-A1 | Oxidizable color producing reagent | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1992-06-03 | — | — | EP | disclosed |
| US-4145364-A | PREPARATION OF FLUORINATED ANILINES | MERCK & CO., INC. (US) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410168-B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | GLP1R, GPR119, GIPR | ALDH1A1 2311/4885TSHR 301/4885PDE10A 1330/4885 |
| US-12391663-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | ALDH1A1 1142/4885TSHR 1114/4885PDE10A 2695/4885 |
| US-20120028923-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | JAK3, JAK2, JAK1 | ALDH1A1 3686/4885TSHR 4061/4885PDE10A 1334/4885 |
| US-20260103463-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | GLP1R, GPR119, GIPR | ALDH1A1 2886/4885TSHR 61/4885PDE10A 713/4885 |
| US-20260055105-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | GLP1R, GIPR, GPR119 | ALDH1A1 2878/4885TSHR 375/4885PDE10A 988/4885 |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | NOS1, NOS3, NOS2 | ALDH1A1 754/4885TSHR 4597/4885PDE10A 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.